These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 16144944)

  • 101. Effective inhibition of irradiation on human gliomas growth in vitro and in vivo after epidermal growth factor receptor silencing with RNA interference.
    Cui G; Zhang T; Wei L; Du P; Zhang F; Chen B; Yin Q; Yan L; Wei J
    Neuroreport; 2011 Oct; 22(15):773-7. PubMed ID: 21876467
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Deletion and tandem duplication of exons 2 - 7 in the epidermal growth factor receptor gene of a human malignant glioma.
    Fenstermaker RA; Ciesielski MJ
    Oncogene; 2000 Sep; 19(39):4542-8. PubMed ID: 11002427
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Synergistic antitumor activity of cetuximab and namitecan in human squamous cell carcinoma models relies on cooperative inhibition of EGFR expression and depends on high EGFR gene copy number.
    De Cesare M; Lauricella C; Veronese SM; Cominetti D; Pisano C; Zunino F; Zaffaroni N; Zuco V
    Clin Cancer Res; 2014 Feb; 20(4):995-1006. PubMed ID: 24327272
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Epidermal growth factor receptor-reactive monoclonal antibodies: xenograft antitumor activity alone and as drug immunoconjugates.
    Gutowski MC; Briggs SL; Johnson DA
    Cancer Res; 1991 Oct; 51(20):5471-5. PubMed ID: 1913667
    [TBL] [Abstract][Full Text] [Related]  

  • 105. In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibody.
    Watanabe Y; Asano R; Arai K; Shimomura I; Ogata H; Kawaguchi H; Hayashi H; Ohtsuka H; Yoshida H; Katayose Y; Egawa S; Nakanishi T; Umetsu M; Yasui H; Ishida T; Imai K; Kudo T; Unno M; Kumagai I
    Oncol Rep; 2011 Oct; 26(4):949-55. PubMed ID: 21743971
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
    Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
    Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
    Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
    Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
    Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
    Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Antisense epidermal growth factor receptor delivered by adenoviral vector blocks tumor growth in human gastric cancer.
    Hirao T; Sawada H; Koyama F; Watanabe A; Yamada Y; Sakaguchi T; Tatsumi M; Fujimoto H; Emoto K; Narikiyo M; Oridate N; Nakano H
    Cancer Gene Ther; 1999; 6(5):423-7. PubMed ID: 10505852
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Antitumour activity of S-1 in combination with cetuximab on human gastric cancer cell lines in vivo.
    Kobunai T; Watanabe T; Fukusato T
    Anticancer Res; 2011 Nov; 31(11):3691-6. PubMed ID: 22110188
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Analysis of the epidermal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation.
    Pedersen MW; Pedersen N; Damstrup L; Villingshøj M; Sønder SU; Rieneck K; Bovin LF; Spang-Thomsen M; Poulsen HS
    J Cell Biochem; 2005 Oct; 96(2):412-27. PubMed ID: 16075456
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK; Modak S
    Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo.
    Saydam O; Glauser DL; Heid I; Turkeri G; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
    Mol Ther; 2005 Nov; 12(5):803-12. PubMed ID: 16112910
    [TBL] [Abstract][Full Text] [Related]  

  • 115. GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab.
    Gerdes CA; Nicolini VG; Herter S; van Puijenbroek E; Lang S; Roemmele M; Moessner E; Freytag O; Friess T; Ries CH; Bossenmaier B; Mueller HJ; Umaña P
    Clin Cancer Res; 2013 Mar; 19(5):1126-38. PubMed ID: 23209031
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo.
    Talon I; Lindner V; Sourbier C; Schordan E; Rothhut S; Barthelmebs M; Lang H; Helwig JJ; Massfelder T
    Carcinogenesis; 2006 Jan; 27(1):73-83. PubMed ID: 16081513
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.
    Modjtahedi H; Moscatello DK; Box G; Green M; Shotton C; Lamb DJ; Reynolds LJ; Wong AJ; Dean C; Thomas H; Eccles S
    Int J Cancer; 2003 Jun; 105(2):273-80. PubMed ID: 12673691
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
    Geoerger B; Kerr K; Tang CB; Fung KM; Powell B; Sutton LN; Phillips PC; Janss AJ
    Cancer Res; 2001 Feb; 61(4):1527-32. PubMed ID: 11245461
    [TBL] [Abstract][Full Text] [Related]  

  • 119. External beam radiation enhances antibody mediated radiocytotoxicity in human glioma cells in vitro.
    Bender H; Emrich JG; Eshelman J; Chu MA; Steplewski Z; Biersack HJ; Brady LW
    Anticancer Res; 1997; 17(3B):1797-802. PubMed ID: 9179236
    [TBL] [Abstract][Full Text] [Related]  

  • 120. RNAi-mediated knockdown of AURKB and EGFR shows enhanced therapeutic efficacy in prostate tumor regression.
    Addepalli MK; Ray KB; Kumar B; Ramnath RL; Chile S; Rao H
    Gene Ther; 2010 Mar; 17(3):352-9. PubMed ID: 19956271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.